Gem Aromatics Limited manufactures and sells specialty ingredients, including essential oils, aroma chemicals, and value-added derivatives, primarily for oral care, cosmetics, personal care, nutraceuticals, pharmaceuticals, wellness, and pain management applications. The company offers over 70 products across four main categories: mint and mint derivatives such as peppermint, spearmint, and menthol; clove and clove derivatives including clove oil, eugenol, and eugenol derivatives; phenol comprising anethole; and other synthetic and natural ingredients such as eucalyptus, eucalyptol, lemongrass, kewra hydrosol, pine oils, orange oils, and mango seed oil. Gem Aromatics operates manufacturing facilities in India, with exports to key markets including the United States, China, Brazil, Singapore, and over 20 other countries, contributing the majority of its revenue from international sales. Incorporated in 1997 and headquartered in Mumbai, India, at A/410 Kailash Complex, Vikhroli Powai Link Road, Vikhroli West, the company holds leading positions in India with approximately 12% share in menthol derivatives by volume and 65% share in eugenol production. In August 2025, Gem Aromatics completed a successful initial public offering on the National Stock Exchange, raising approximately INR 4.51 billion through a fresh issue of INR 1.75 billion and an offer for sale of INR 2.76 billion, which was oversubscribed 21.71 times.